Covered recipient · General Payments record
KIMBERLY ANN ALLEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$615.77
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $533.07 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $306.59 | 18 |
| Acerta Pharma LLC | $89.35 | 3 |
| Amgen Inc. | $50.21 | 3 |
| Novo Nordisk AS | $33.22 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.66 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.19 | 1 |
| GlaxoSmithKline, LLC. | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.25 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428636 | CMS |
| ABBVIE INC. | $20.04 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428638 | CMS |
| ABBVIE INC. | $24.85 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428640 | CMS |
| ABBVIE INC. | $1.96 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428642 | CMS |
| ABBVIE INC. | $31.90 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428644 | CMS |
| ABBVIE INC. | $28.77 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428646 | CMS |
| ABBVIE INC. | $14.02 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428648 | CMS |
| ABBVIE INC. | $29.97 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428650 | CMS |
| ABBVIE INC. | $4.05 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428652 | CMS |
| ABBVIE INC. | $11.10 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428654 | CMS |
| ABBVIE INC. | $19.69 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428656 | CMS |
| ABBVIE INC. | $14.96 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428658 | CMS |
| ABBVIE INC. | $15.85 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428660 | CMS |
| ABBVIE INC. | $2.43 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428662 | CMS |
| ABBVIE INC. | $17.64 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428664 | CMS |
| ABBVIE INC. | $21.27 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428666 | CMS |
| ABBVIE INC. | $17.53 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428668 | CMS |
| ABBVIE INC. | $16.31 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106428670 | CMS |
| Amgen Inc. | $14.52 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117492728 | CMS |
| Amgen Inc. | $18.16 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117492730 | CMS |
| Amgen Inc. | $17.53 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117492732 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.83 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104608050 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.54 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104583344 | CMS |
| AstraZeneca Pharmaceuticals LP | $53.98 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104312764 | CMS |
| GlaxoSmithKline, LLC. | $13.85 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116625880 | CMS |
| Novo Nordisk Inc | $19.50 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100568276 | CMS |
| Novo Nordisk Inc | $13.72 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100345140 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.19 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153596013 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.66 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631651 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.